The Current Ratio as of November 2024 (TTM) for Angion Biomedica Corp. (ANGN) is 1.74

According to Angion Biomedica Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 1.74. This represents a change of -79.13% compared to the average of 8.32 of the last 4 quarters.

Angion Biomedica Corp. (ANGN) Historical Current Ratio (quarterly & annually)

How has ANGN Current Ratio performed in the past?

The mean historical Current Ratio of Angion Biomedica Corp. over the last ten years is 3.05. The current 1.74 Current Ratio has changed 5.58% with respect to the historical average. Over the past ten years (40 quarters), ANGN's Current Ratio was at its highest in in the March 2023 quarter at 20.00. The Current Ratio was at its lowest in in the March 2013 quarter at 0.

Angion Biomedica Corp. (ANGN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Angion Biomedica Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Angion Biomedica Corp. (ANGN) Average Current Ratio

How has ANGN Current Ratio performed in the past?

The current Current Ratio of Angion Biomedica Corp. (ANGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Angion Biomedica Corp. (ANGN) Current Ratio vs. Peers

How is ANGN’s Current Ratio compared to its peers?

Angion Biomedica Corp.’s Current Ratio is greater than eFFECTOR Therapeutics, Inc. (1.03), less than Landos Biopharma, Inc. (4.43), greater than Apexigen, Inc. (1.29), greater than Navidea Biopharmaceuticals, Inc. (0.56), less than Oncorus, Inc. (1.74), less than Apollomics, Inc. (2.25), less than Sigilon Therapeutics, Inc. (2.40), less than Pyxis Oncology, Inc. (7.33), less than Zura Bio Limited (10.36), greater than Altamira Therapeutics Ltd. (1.38), less than Elevation Oncology, Inc. (17.77), greater than ZyVersa Therapeutics, Inc. (0.03), less than Palisade Bio, Inc. (3.31), less than Unicycive Therapeutics, Inc. (3.61), less than Immix Biopharma, Inc. (3.47),

Build a custom stock screener for Angion Biomedica Corp. (ANGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Angion Biomedica Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Angion Biomedica Corp. (ANGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Angion Biomedica Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.